Literature DB >> 27417740

Association between atrial fibrillation and volumetric magnetic resonance imaging brain measures: Framingham Offspring Study.

Ryan J Piers1, Arvind Nishtala2, Sarah R Preis3, Charles DeCarli4, Philip A Wolf1, Emelia J Benjamin5, Rhoda Au6.   

Abstract

BACKGROUND: The increased risk of stroke and cognitive impairment associated with atrial fibrillation (AF) is well documented. However, there is a paucity of research investigating the relations between AF and brain morphology.
OBJECTIVE: The purpose of this study was to investigate the association between AF and brain volume measures on magnetic resonance imaging (MRI).
METHODS: The study sample included stroke- and dementia-free participants who attended the Framingham Heart Study offspring cohort 7th examination cycle (1999-2005) and underwent contemporaneous MRI. We examined the association between prevalent AF and brain volume measures (total cerebral volume, frontal lobe volume, temporal lobe volume, temporal horn volume, hippocampal volume, and white matter hyperintensity volume) with linear regression. We first adjusted models for age and sex, and then for vascular risk factors and APOE4.
RESULTS: We studied 2144 individuals (mean age 61.8 ± 9.3 years; 54% women); 73 participants (3.4%) had prevalent AF at the time of MRI. In age- and sex-adjusted models, AF was inversely associated with total cerebral brain volume, frontal brain volume, and temporal brain volume. After further adjustment for vascular risk factors and APOE4, AF remained associated with frontal brain volume.
CONCLUSION: After accounting for vascular risk factor burden, prevalent AF was associated with lobar indexes of vascular brain aging but not with expected white matter changes.
Copyright © 2016 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Brain volume; Framingham; Imaging; Magnetic resonance imaging

Mesh:

Year:  2016        PMID: 27417740      PMCID: PMC5035234          DOI: 10.1016/j.hrthm.2016.07.004

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  25 in total

1.  Measures of brain morphology and infarction in the framingham heart study: establishing what is normal.

Authors:  Charles DeCarli; Joseph Massaro; Danielle Harvey; John Hald; Mats Tullberg; Rhoda Au; Alexa Beiser; Ralph D'Agostino; Philip A Wolf
Journal:  Neurobiol Aging       Date:  2005-04       Impact factor: 4.673

2.  Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population.

Authors:  Susan Colilla; Ann Crow; William Petkun; Daniel E Singer; Teresa Simon; Xianchen Liu
Journal:  Am J Cardiol       Date:  2013-07-04       Impact factor: 2.778

3.  Impact of apolipoprotein E epsilon4 and vascular disease on brain morphology in men from the NHLBI twin study.

Authors:  C DeCarli; T Reed; B L Miller; P A Wolf; G E Swan; D Carmelli
Journal:  Stroke       Date:  1999-08       Impact factor: 7.914

4.  Correlation between rates of brain atrophy and cognitive decline in AD.

Authors:  N C Fox; R I Scahill; W R Crum; M N Rossor
Journal:  Neurology       Date:  1999-05-12       Impact factor: 9.910

5.  Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007.

Authors:  Jonathan P Piccini; Bradley G Hammill; Moritz F Sinner; Paul N Jensen; Adrian F Hernandez; Susan R Heckbert; Emelia J Benjamin; Lesley H Curtis
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-01-10

6.  Silent brain infarcts and the risk of dementia and cognitive decline.

Authors:  Sarah E Vermeer; Niels D Prins; Tom den Heijer; Albert Hofman; Peter J Koudstaal; Monique M B Breteler
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

7.  Hippocampal atrophy, whole brain volume, and white matter lesions in older hypertensive subjects.

Authors:  R M Wiseman; B K Saxby; E J Burton; R Barber; G A Ford; J T O'Brien
Journal:  Neurology       Date:  2004-11-23       Impact factor: 9.910

8.  Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy.

Authors:  Stefan Knecht; Christian Oelschläger; Thomas Duning; Hubertus Lohmann; Johannes Albers; Christoph Stehling; Walter Heindel; Günter Breithardt; Klaus Berger; E Bernd Ringelstein; Paulus Kirchhof; Heike Wersching
Journal:  Eur Heart J       Date:  2008-07-29       Impact factor: 29.983

9.  Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging.

Authors:  Henry Rusinek; Susan De Santi; Dina Frid; Wai-Hon Tsui; Chaim Y Tarshish; Antonio Convit; Mony J de Leon
Journal:  Radiology       Date:  2003-12       Impact factor: 11.105

10.  Atrial fibrillation is associated with lower cognitive performance in the Framingham offspring men.

Authors:  Merrill F Elias; Lisa M Sullivan; Penelope K Elias; Ramachandran S Vasan; Ralph B D'Agostino; Sudha Seshadri; Rhoda Au; Philip A Wolf; Emelia J Benjamin
Journal:  J Stroke Cerebrovasc Dis       Date:  2006 Sep-Oct       Impact factor: 2.136

View more
  11 in total

1.  Atrial fibrillation and cognitive decline in the Framingham Heart Study.

Authors:  Arvind Nishtala; Ryan J Piers; Jayandra J Himali; Alexa S Beiser; Kendra L Davis-Plourde; Jane S Saczynski; David D McManus; Emelia J Benjamin; Rhoda Au
Journal:  Heart Rhythm       Date:  2017-09-22       Impact factor: 6.343

2.  Laser catheter ablation of long- lasting persistent atrial fibrillation: Longterm results.

Authors:  Helmut Weber; Michaela Sagerer-Gerhardt; Armin Heinze
Journal:  J Atr Fibrillation       Date:  2017-08-31

Review 3.  Atrial fibrillation, cognition and dementia: A review.

Authors:  Summer Aldrugh; Mayank Sardana; Nils Henninger; Jane S Saczynski; David D McManus
Journal:  J Cardiovasc Electrophysiol       Date:  2017-06-21

4.  Atrial Fibrillation and Brain Magnetic Resonance Imaging Abnormalities.

Authors:  Jeremy P Berman; Faye L Norby; Thomas Mosley; Elsayed Z Soliman; Rebecca F Gottesman; Pamela L Lutsey; Alvaro Alonso; Lin Y Chen
Journal:  Stroke       Date:  2019-04       Impact factor: 7.914

5.  Atrial Fibrillation, Brain Volumes, and Subclinical Cerebrovascular Disease (from the Atherosclerosis Risk in Communities Neurocognitive Study [ARIC-NCS]).

Authors:  Kasra Moazzami; Iris Yuefan Shao; Lin Yee Chen; Pamela L Lutsey; Clifford R Jack; Thomas Mosley; David A Joyner; Rebecca Gottesman; Alvaro Alonso
Journal:  Am J Cardiol       Date:  2019-10-26       Impact factor: 2.778

6.  Association Between Elevated Depressive Symptoms and Cognitive Function Moderated by APOE4 Status: Framingham Offspring Study.

Authors:  Ryan J Piers; Yulin Liu; Ting F A Ang; Qiushan Tao; Rhoda Au; Wei Qiao Qiu
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

7.  Association of Atrial Fibrillation With Cognitive Decline and Dementia Over 20 Years: The ARIC-NCS (Atherosclerosis Risk in Communities Neurocognitive Study).

Authors:  Lin Y Chen; Faye L Norby; Rebecca F Gottesman; Thomas H Mosley; Elsayed Z Soliman; Sunil K Agarwal; Laura R Loehr; Aaron R Folsom; Josef Coresh; Alvaro Alonso
Journal:  J Am Heart Assoc       Date:  2018-03-07       Impact factor: 5.501

Review 8.  Atrial Fibrillation, Cognitive Decline, and Dementia: an Epidemiologic Review.

Authors:  Mozhu Ding; Chengxuan Qiu
Journal:  Curr Epidemiol Rep       Date:  2018-07-07

9.  Atrial Fibrillation, Stroke, and Silent Cerebrovascular Disease: A Population-based MRI Study.

Authors:  Lina Rydén; Simona Sacuiu; Hanna Wetterberg; Jenna Najar; Xinxin Guo; Silke Kern; Anna Zettergren; Sara Shams; Joana B Pereira; Lars-Olof Wahlund; Eric Westman; Ingmar Skoog
Journal:  Neurology       Date:  2021-09-14       Impact factor: 9.910

10.  Predictive role of atrial fibrillation in cognitive decline: a systematic review and meta-analysis of 2.8 million individuals.

Authors:  Yu Han Koh; Leslie Z W Lew; Kyle B Franke; Adrian D Elliott; Dennis H Lau; Anand Thiyagarajah; Dominik Linz; Margaret Arstall; Phillip J Tully; Bernhard T Baune; Dian A Munawar; Rajiv Mahajan
Journal:  Europace       Date:  2022-09-01       Impact factor: 5.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.